Methyl Alcohol

Methyl Alcohol

SCHEMBL929694

CO.Cc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)c(O)c1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.66
CHRM2 P08172 1/20 0.66
HTR1A P08908 1/20 0.66
ADRA2A P08913 1/20 0.66
CHRM1 P11229 1/20 0.66
DRD2 P14416 1/20 0.66
ADRA2B P18089 1/20 0.66
ADRA2C P18825 1/20 0.66
DRD1 P21728 1/20 0.66
DRD4 P21917 1/20 0.66
ACHE P22303 1/20 0.66
SLC6A2 P23975 1/20 0.66
HTR2A P28223 1/20 0.66
HTR2C P28335 1/20 0.66
SLC6A4 P31645 1/20 0.66
CCKBR P32239 1/20 0.66
ADRA1A P35348 1/20 0.66
HRH1 P35367 1/20 0.66
OPRM1 P35372 1/20 0.66
DRD3 P35462 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL142049 0.89 ABCB11 (0.66) ABCB11CHRM2HTR1AADRA2ACHRM1
SCHEMBL9101152 0.89 HTR1A (0.68) ABCB11CHRM2HTR1AADRA2ACHRM1
SCHEMBL8346535 0.89 HTR1A (0.77) ABCB11CHRM2HTR1AADRA2ACHRM1
Alcohol SCHEMBL142048 0.88 DRD2 (0.66) ABCB11CHRM2HTR1AADRA2ACHRM1
Methane SCHEMBL7348385 0.87 HTR1A (0.65) ABCB11CHRM2HTR1AADRA2ACHRM1
SCHEMBL1545992 0.87 ABCB11 (0.64) ABCB11CHRM2HTR1AADRA2ACHRM1
SCHEMBL142061 0.87 ABCB11 (0.83) ABCB11CHRM2HTR1AADRA2ACHRM1
SCHEMBL1544782 0.87 ABCB11 (0.73) ABCB11CHRM2HTR1AADRA2ACHRM1
SCHEMBL8560316 0.86 HTR1A (0.67) ABCB11CHRM2HTR1AADRA2ACHRM1
SCHEMBL1545714 0.86 HTR1A (0.64) ABCB11CHRM2HTR1AADRA2ACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152917-B1 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS VANDA PHARMACEUTICALS INC (US) 2016-03-23 EP disclosed
US-9080214-B2 Genetic markers for efficacy of iloperidone in the treatment of psychotic symptoms VANDA PHARMACEUTICALS, INC. (US) 2015-07-14 US disclosed
US-20110021566-A1 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS VANDA PHARMACEUTICALS, INC. 2011-01-27 US disclosed
EP-2152917-A2 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS Vanda Pharmaceuticals Inc. (US) 2010-02-17 EP disclosed
WO-2008144599-A2 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS VANDA PHARMACEUTICALS INC. (US) 2008-11-27 WO disclosed